Moderna Inc. stock falls Thursday, underperforms market

© Terrence Horan


Shares of Moderna Inc. MRNA slipped 0.57% to $155.69 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.54% to 12,405.81 and the Dow Jones Industrial Average DJIA falling 0.23% to 29,999.26. This was the stock’s second consecutive day of losses. Moderna Inc. closed $22.81 short of its 52-week high ($178.50), which the company reached on December 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. ABBV fell 1.09% to $107.49, Amgen Inc. AMGN fell 0.74% to $228.16, and AstraZeneca PLC ADR AZN fell 0.28% to $53.89. Trading volume (21.8 M) eclipsed its 50-day average volume of 18.3 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading